The prevention of systemic arteriosclerosis.
D000450:Aldosterone / Q000032:analysis; D001161:Arteriosclerosis / Q000150:complications / Q000517:prevention & control*; D002118:Calcium / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D003480:Cushing Syndrome / Q000150:complications; D048909:Diabetes Complications; D005247:Feeding Behavior; D006073:Gout / Q000150:complications; D006801:Humans; D006929:Hyperaldosteronism / Q000150:complications; D006973:Hypertension / Q000150:complications; D007545:Isoproterenol / Q000032:analysis; D050356:Lipid Metabolism; D009538:Nicotine / Q000009:adverse effects; D009638:Norepinephrine / Q000378:metabolism; D009765:Obesity / Q000628:therapy; D010673:Pheochromocytoma / Q000150:complications; D011704:Pyelonephritis / Q000150:complications; D012083:Renin / Q000032:analysis; D012907:Smoking; D013315:Stress, Psychological
D002395:Catecholamines; D002792:Cholestyramine Resin; D000450:Aldosterone; D009538:Nicotine; D002784:Cholesterol; D012083:Renin; D002994:Clofibrate; D007545:Isoproterenol; D002118:Calcium; D009638:Norepinephrine